NATALIA
CHUECA PORCUNA
Investigadora en el periodo 2007-2008
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (14)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
2020
-
A multi-omics approach reveals new signatures in obese allergic asthmatic children
Biomedicines, Vol. 8, Núm. 9
-
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain
HIV Medicine, Vol. 21, Núm. 2, pp. 128-134
-
Study of the fetal and maternal microbiota in pregnant women with intrauterine growth restriction and its relationship with inflammatory biomarkers: A case-control study protocol (SPIRIT compliant)
Medicine, Vol. 99, Núm. 46, pp. e22722
2019
-
Association of breast and gut microbiota dysbiosis and the risk of breast cancer: A case-control clinical study
BMC Cancer, Vol. 19, Núm. 1
-
Autism spectrum disorder (ASD) with and without mental regression is associated with changes in the fecal microbiota
Nutrients, Vol. 11, Núm. 2
-
Lactobacillus reuteri v3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome: The PROSIR study
Nutrients, Vol. 11, Núm. 8
2018
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
2017
-
Obesity and asthma: A missing link
International Journal of Molecular Sciences, Vol. 18, Núm. 7
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
2016
2015
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5